DENTSPLY SIRONA Inc. (NASDAQ:XRAY) had its price objective boosted by stock analysts at Stifel Nicolaus from $66.00 to $70.00 in a research report issued to clients and investors on Monday. The firm currently has a “buy” rating on the medical instruments supplier’s stock. Stifel Nicolaus’ price objective indicates a potential upside of 8.73% from the stock’s current price.

A number of other research analysts also recently commented on XRAY. Barrington Research raised DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $73.00 target price on the stock in a report on Monday. HC Wainwright reaffirmed a “buy” rating and set a $68.00 target price (down previously from $74.00) on shares of DENTSPLY SIRONA in a report on Monday, August 14th. UBS AG reaffirmed a “neutral” rating and set a $59.00 target price (down previously from $62.00) on shares of DENTSPLY SIRONA in a report on Thursday, August 10th. TheStreet downgraded DENTSPLY SIRONA from a “b” rating to a “c+” rating in a report on Wednesday, August 9th. Finally, Zacks Investment Research downgraded DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a report on Monday, October 30th. Three analysts have rated the stock with a sell rating, two have given a hold rating and seven have assigned a buy rating to the stock. DENTSPLY SIRONA has a consensus rating of “Hold” and a consensus target price of $67.00.

DENTSPLY SIRONA (NASDAQ XRAY) opened at $64.38 on Monday. The company has a current ratio of 2.32, a quick ratio of 1.59 and a debt-to-equity ratio of 0.21. DENTSPLY SIRONA has a 1-year low of $52.53 and a 1-year high of $67.95. The company has a market capitalization of $14,700.00, a P/E ratio of 25.82, a price-to-earnings-growth ratio of 2.66 and a beta of 1.27.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Friday, November 3rd. The medical instruments supplier reported $0.70 EPS for the quarter, topping analysts’ consensus estimates of $0.66 by $0.04. DENTSPLY SIRONA had a positive return on equity of 7.56% and a negative net margin of 20.33%. The company had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $978.99 million. During the same quarter last year, the business posted $0.66 EPS. DENTSPLY SIRONA’s quarterly revenue was up 5.8% compared to the same quarter last year. sell-side analysts expect that DENTSPLY SIRONA will post 2.67 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another website, it was illegally copied and republished in violation of US & international copyright & trademark laws. The original version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/11/08/stifel-nicolaus-increases-dentsply-sirona-inc-xray-price-target-to-70-00.html.

Institutional investors have recently made changes to their positions in the company. Commonwealth Bank of Australia raised its position in shares of DENTSPLY SIRONA by 19.0% during the 2nd quarter. Commonwealth Bank of Australia now owns 1,626 shares of the medical instruments supplier’s stock worth $104,000 after purchasing an additional 260 shares during the period. Acrospire Investment Management LLC acquired a new stake in shares of DENTSPLY SIRONA during the 2nd quarter worth approximately $113,000. Dupont Capital Management Corp acquired a new stake in shares of DENTSPLY SIRONA during the 2nd quarter worth approximately $116,000. Massey Quick Simon & CO. LLC acquired a new stake in shares of DENTSPLY SIRONA during the 3rd quarter worth approximately $124,000. Finally, Korea Investment CORP raised its position in shares of DENTSPLY SIRONA by 139.9% during the 2nd quarter. Korea Investment CORP now owns 2,145 shares of the medical instruments supplier’s stock worth $139,000 after purchasing an additional 1,251 shares during the period. Institutional investors and hedge funds own 93.71% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Stock Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related stocks with our FREE daily email newsletter.